Largest beer brewer to use sustainable PEF bottles
Avantium and AmBev, part of AB InBev Group, have inked an agreement on PEF for soft drink bottles.
Vector Biopharma kicks of with CHF30m Series A financing
With a Series A funding of CHF 30m from Versant Ventures, Vector Biopharma AG set out to solve several of the current gene delivery problems.
Two deaths with Novartis gene therapy
Swiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma.
Azenta set to acquire B Medical Systems
Azenta Inc has entered into an agreement to acquire B Medical Systems S.á r.l. and its subsidiaries for 410m.
Sartorius pays £415m for Albumedix Ltd
Sartorius Stedim Biotech has purchased the world’s largest human albumin producer Albumedix to broaden its product portfolio in animal-free cell media and to stabilise protein drugs.
BioNtech SE expands collab with Genmab A/S
As Genmabs Hexabody tumour antibody platform is advancing, BioNTech has secured a licence in the field of immunotherapy to co-develop antibodies on 50:50 base.
F2G to use $70m financing to advance olorofilm
British antifungal developer F2G Ltd has announced a $70mn financing round to push development of its late-stage compound olorofilm.
Sosei announces $1.2bn R&D collaboration with Abbvie
Sosei Heptares and AbbVie have inked a multi-target licence option drug discovery agreement in neurology.
UK-Spanish team to optimise efficacy of microbial production processes
Researchers have presented a novel method to promote biofilm formation and thus to increase efficiency of biocatalysis in biotech production.
InflaRX set to file for MAA for vilobelimab
InflaRx plans to apply for Emergency Use Authorization from the US FDA in Q3/2022 for vilobelimab, the company’s treatment for critically ill COVID-19 patients.